Help Move the Industry Forward: Submit Your Abstract for Cannabis Science Conference Fall 2023
You are invited to submit your oral and poster abstracts for the next Cannabis Science Conference taking place in Providence, Rhode Island, on September 20-22!
Share your research or best practices with your peers! Submit your abstract here by Monday, June 12th, 2023 for consideration!
All oral and poster abstract submissions must be made electronically through the conference’s online abstract submission system.
Your abstract should be a short description of your work and contain all the elements necessary to define your goals and results to the reader.
Categories of submission include the following:
- Analytical Science (QC/QA Testing, Processing, Research and Regulations)
- Medical Cannabis
- Cultivation Science
- Psychedelics
- Poster Presentation
The review committee will evaluate the scientific or medical quality of the submitted abstracts based on the following criteria: novelty of the research, significance of the findings, and clarity. Incomplete abstracts will not be reviewed. All PDF abstract submissions must include the abstract title, co-authors listed, the full abstract, and indicate if this is an encore presentation and, if so, where it was previously presented.
Notification of acceptance or regret will be delivered via email to the presenter(s) of each abstract by June 30, 2023.
If accepted for presentation, oral submissions will take place in our Analytical, Medical, Cultivation or Psychedelic tracks/session rooms. The posters will be displayed in the exhibit hall for the length of the conference, attendance is required at the event. The presentation at the 2023 Cannabis Science Conference Fall should reflect the submitted abstract, abstract title, authorship, and content. All accepted presenters will be automatically registered to attend the conference and will also be provided with a plus one complimentary registration to bring a guest.
Submission Process
- Complete the abstract template provided on the 2023 Cannabis Science Conference Fall website.
- Limit is 250 words (abstract body).
- Title limit 100 characters (with spaces)
Please submit any questions pertaining to abstract submissions to info@mjhlifesciences.com using the subject line "2023 CSC Fall Abstract QUESTION."
Author Consent and Waiver of Claims
- Each abstract author agrees and certifies that he or she:
- Waives any and all claims against MJH Life Sciences and Cannabis Science Conference, and any review arising out of or relating to the abstract submission and review process, including but not limited to peer review and the grading of abstracts.
Abstract Format
- The title of the abstract should be brief and objectively describe the work submitted.
- First Author (Presenting Author): The name, institution, telephone number, and email address of the First Author are required. The First Author (Presenting Author) will receive all future correspondence from CSC.
- Abstracts should not exceed 250 words (body of the abstract)
- Standard abbreviations may be used and must be spelled out and defined at the first use (put in parentheses immediately after the first mention of a term or phrase).
- The abstract must be submitted in English.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
